Currently, most health care systems cannot afford all possible health care technologies and thus face serious resource allocation decisions. Economic evaluation represents one important tool to support decision-makers tackle this issue. The economic evaluation of infectious diseases is typically trickier than comparable analysis of other diseases. This book initially analyzes the differences between economic evaluation of infectious and non-infectious diseases and subsequently presents methodological advances for conducting the former, using real world examples. Guidance, especially, on the use of dynamic versus static models; on the assessment of indirect costs and the transferability of study results from one country to another country is given.
Frankfurt am Main, Berlin, Bern, Bruxelles, New York, Oxford, Wien, 2007. 194 pp., 17 fig., 26 tables
Contents: Cost-effectiveness of screening for genital Chlamydia trachomatis infections – Cost-effectiveness of screening
programs for Chlamydia trachomatis: a population based dynamic approach – Cost and effects of chlamydial screening programs:
dynamic versus static modeling – The role of economic evaluation in vaccine decision making: focus on meningococcal group
C conjugate vaccine – Economic evaluation of meningococcal serogroup C conjugate vaccination programs in The Netherlands and
its impact on decision making – A decision chart for assessing and improving the transferability of economic evaluation results